Reflux and Barrett’s Esophagus

There is an estimated 60% of adults suffering with some form of heartburn or gastroesophageal reflux disease (GERD). Of that 60% of individuals, 20% having symptoms weekly and 20% use some form of over-the-counter antacids, proton pump inhibitors (PPIs), or H2 antagonists to combat symptoms. Patients are seen in outpatient clinics by Family Nurse Practitioners or Physicians and spend a projected $142 billion dollars annually on medications to treat the symptoms and harmful side effects of the disease. Despite treatment for GERD, many patients likely affected by the disease will progress into esophagitis or a more serious complication known as Barrett’s disease. The purpose of this project is to increase healthcare provider’s awareness of individuals who might be at higher risk seeking medical attention at outpatient clinics with symptoms of heartburn or GERD, discuss screening, treatment options, and potential risk factors of progression of the disease with or without treatment. By presenting information at a local health fair, to MAN students, and fellow NPs through pre and post surveys, I was to identify their gaps in knowledge, educate on the disease process, and treatment options to hopeful prevent the progression of disease. The Doctoral Nurse Practitioner (DNP) essentials for advanced practice were utilized for identification, development, implementation, and evaluation